Poor glycemic control is associated with reduced prostate specific antigen concentrations in men with type 1 diabetes (Q35186197)

7 August 2017

Poor glycemic control is associated with reduced prostate specific antigen concentrations in men with type 1 diabetes (English)

1 reference

7 August 2017

1 reference

2

James Hotaling

1 reference

7 August 2017

12

Hunter Wessells

1 reference

7 August 2017

Aruna V Sarma

1

1 reference

7 August 2017

Rodney L Dunn

3

1 reference

7 August 2017

Patricia A Cleary

4

1 reference

7 August 2017

Barbara H Braffett

5

1 reference

7 August 2017

Catherine Kim

6

1 reference

7 August 2017

Catherine Martin

7

1 reference

7 August 2017

William Herman

8

1 reference

7 August 2017

Patricia Gatcomb

9

1 reference

7 August 2017

Alan M Jacobson

10

1 reference

7 August 2017

Sarah K Holt

11

1 reference

7 August 2017

DCCT/EDIC Research Group

13

1 reference

7 August 2017

language of work or name

English

0 references

publication date

11 September 2014

1 reference

7 August 2017

1 reference

7 August 2017

193

1 reference

7 August 2017

786-793

1 reference

7 August 2017

3

1 reference

Serum glucose and fructosamine in relation to risk of cancer

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4363040

13 July 2018

Cancer statistics, 2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4363040

Diabetes mellitus and prostate cancer risk of different grade or stage: a systematic review and meta-analysis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4363040

Prostate-specific antigen testing in older men in the USA: data from the behavioral risk factor surveillance system

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4363040

The effects of type 2 diabetes and hypertension on changes in serum prostate specific antigen levels: results from the Olmsted County study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4363040

Impact of common medications on serum total prostate-specific antigen levels: analysis of the National Health and Nutrition Examination Survey

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4363040

Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001-2004.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4363040

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4363040

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4363040

Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4363040

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4363040

Type 2 diabetes mellitus, glycemic control, and cancer risk.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4363040

Diabetes mellitus and prostate cancer risk; a nationwide case-control study within PCBaSe Sweden

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4363040

Relationship between changes in haemoglobin A1C and prostate-specific antigen in healthy men.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4363040

Association of diabetes and body mass index with levels of prostate-specific antigen: implications for correction of prostate-specific antigen cutoff values?

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4363040

The influence of statin medications on prostate-specific antigen levels

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4363040

Obesity and screening PSA levels among men undergoing an annual physical exam.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4363040

Association between prostate-specific antigen and leptin, adiponectin, HbA1c or C-peptide among African-American and Caucasian men.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4363040

Prostate-specific antigen values in diabetic and nondiabetic US men, 2001-2002.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4363040

Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4363040

The association of body mass index and prostate-specific antigen in a population-based study

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4363040

A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy

27 September 2018

1 reference

12 December 2020

A meta-analysis of diabetes mellitus and the risk of prostate cancer

1 reference

12 December 2020

Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004

1 reference

12 December 2020

Serum prostate-specific antigen levels in men with type 2 diabetes

1 reference

12 December 2020

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

1 reference

12 December 2020

Why does diabetes offer protective effects against prostate cancer? The possible role of its microvascular complications

1 reference

12 December 2020

Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7

1 reference

12 December 2020

10.1016/J.JURO.2014.08.115

Identifiers

DOI

1 reference

7 August 2017

1 reference

7 August 2017

1 reference